BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 26202489)

  • 1. Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?
    Ha KY; Park KS; Kim SI; Kim YH
    Osteoporos Int; 2016 Feb; 27(2):483-8. PubMed ID: 26202489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anti-osteoporosis medications on radiological and clinical results after acute osteoporotic spinal fractures: a retrospective analysis of prospectively designed study.
    Min HK; Ahn JH; Ha KY; Kim YH; Kim SI; Park HY; Rhyu KW; Kim YY; Oh IS; Seo JY; Chang DG; Cho JH
    Osteoporos Int; 2019 Nov; 30(11):2249-2256. PubMed ID: 31420700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
    Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
    J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology of fracture healing in osteoporosis and in the presence of anti-osteoporotic drugs.
    Hak DJ
    Injury; 2018 Aug; 49(8):1461-1465. PubMed ID: 29709376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates and their influence on fracture healing: a systematic review.
    Molvik H; Khan W
    Osteoporos Int; 2015 Apr; 26(4):1251-60. PubMed ID: 25572046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between clinical symptoms of osteoporotic vertebral fracture with intravertebral cleft and radiographic findings.
    Nakamae T; Fujimoto Y; Yamada K; Hiramatsu T; Hashimoto T; Olmarker K; Adachi N
    J Orthop Sci; 2017 Mar; 22(2):201-206. PubMed ID: 28081928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do bisphosphonates affect fracture healing?
    Kates SL; Ackert-Bicknell CL
    Injury; 2016 Jan; 47 Suppl 1(0 1):S65-8. PubMed ID: 26768295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Hansen L; Petersen KD; Eriksen SA; Gerstoft F; Vestergaard P
    Osteoporos Int; 2017 Jan; 28(1):321-328. PubMed ID: 27475930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of teriparatide in osteoporotic fracture patients.
    Collinge C; Favela J
    Injury; 2016 Jan; 47 Suppl 1():S36-8. PubMed ID: 26768289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM
    Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study.
    Kang JS; Won YY; Kim JO; Min BW; Lee KH; Park KK; Song JH; Kim YT; Kim GH
    Int Orthop; 2014 Jun; 38(6):1247-53. PubMed ID: 24464018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of osteoporosis medications on fracture healing.
    Hegde V; Jo JE; Andreopoulou P; Lane JM
    Osteoporos Int; 2016 Mar; 27(3):861-871. PubMed ID: 26419471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early initiation of bisphosphonate does not affect healing and outcomes of volar plate fixation of osteoporotic distal radial fractures.
    Gong HS; Song CH; Lee YH; Rhee SH; Lee HJ; Baek GH
    J Bone Joint Surg Am; 2012 Oct; 94(19):1729-36. PubMed ID: 22992762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Early Bisphosphonate Administration for Fracture Healing in Patients with Osteoporotic Proximal Humerus Fractures.
    Seo JB; Yoo JS; Ryu JW; Yu KW
    Clin Orthop Surg; 2016 Dec; 8(4):437-443. PubMed ID: 27904727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-associated femur fractures have high complication rates with operative fixation.
    Prasarn ML; Ahn J; Helfet DL; Lane JM; Lorich DG
    Clin Orthop Relat Res; 2012 Aug; 470(8):2295-301. PubMed ID: 22669553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails.
    Egol KA; Park JH; Rosenberg ZS; Peck V; Tejwani NC
    Clin Orthop Relat Res; 2014 Sep; 472(9):2728-34. PubMed ID: 23604648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonate use after clinical fracture and risk of new fracture.
    Bergman J; Nordström A; Nordström P
    Osteoporos Int; 2018 Apr; 29(4):937-945. PubMed ID: 29397408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of clinical outcomes in patients with osteoporotic vertebral compression fractures (OVCFs): conservative treatment versus balloon kyphoplasty.
    Lee HM; Park SY; Lee SH; Suh SW; Hong JY
    Spine J; 2012 Nov; 12(11):998-1005. PubMed ID: 23026068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
    Wang CC; Lu HT; Dusetzina SB; Wu CH
    J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication management after intramedullary nailing of atypical fractures.
    Feron JM; Cambon-Binder A
    Injury; 2017 Jun; 48 Suppl 1():S15-S17. PubMed ID: 28456365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.